Elon Musk denies drug accusations and attacks the New York Times in an Oval Office statement

This account paints a deeply troubling picture of Elon Musk’s alleged conduct and influence during his time in Donald Trump’s administration, particularly as head of the so-called “Department of Government Efficiency” (DOGE). Key concerns raised in the New York Times report revolve around:

1. Alleged Drug Use:
   Despite Musk’s public statements claiming occasional, controlled ketamine use—"small doses every two weeks" as told to Don Lemon—insiders report far more frequent consumption. Allegedly, Musk used ketamine daily at times, alongside other substances like ecstasy and psychedelic mushrooms. This behavior, if true, could have affected his ability to function effectively in a high-level government advisory role. Reports even mention physical side effects such as bladder issues.

2. Unpredictable and Erratic Behavior:
   Sources describe Musk’s conduct as increasingly volatile during his government tenure—allegedly insulting cabinet members, exhibiting combative behavior, and even making a gesture that resembled a Nazi salute at a political rally. That incident, in particular, triggered widespread public condemnation and further questions about his judgment.

3. Influence Within the Administration:
   Musk’s $275 million donation to Trump’s campaign reportedly enhanced his access and sway. Though his title was technically that of a “special government employee” (which comes with fewer restrictions than full-time officials), he occupied a visible and influential role, which makes the allegations especially alarming.

4. Drug Policy Hypocrisy and Loopholes:
   The contradiction between SpaceX’s strict drug policy and Musk’s alleged behavior is stark. Sources allege he was tipped off about random drug tests, suggesting systemic favoritism or breakdowns in oversight. His status also allowed him to bypass certain federal drug-use policies, leading critics to argue that the system was bent to accommodate him.

5. Dismissive Responses from Key Figures:
   Musk’s response to the New York Times report during his farewell speech was to attack the publication itself, invoking right-wing talking points about “Russia-gate” and its Pulitzer Prize. Similarly, White House Deputy Chief of Staff Stephen Miller deflected questions about Musk’s drug use by invoking immigration-related concerns, offering no substantive defense or clarification.

6. Public and Intellectual Reaction:
   Perhaps one of the most telling reactions came from Sam Harris, once a public ally of Musk, who wrote: “There is something seriously wrong with his moral compass, if not his perception of reality.” This reflects a growing unease in intellectual and political circles about Musk's reliability and ethics, especially when placed in a position of public power.

---

Context & Implications:

While Elon Musk remains a towering figure in tech and public discourse, these revelations—if substantiated—could have long-term reputational and legal implications. They raise difficult questions about:

• Vetting and accountability of influential private citizens in government roles

• The ethical limits of political donations and appointments

• Systemic double standards in drug enforcement and corporate governance

The report also underscores broader concerns about the normalization of erratic behavior in high offices, especially when it comes from individuals with immense financial and technological influence.